Newtyn Management, LLC Alector, Inc. Transaction History

Newtyn Management, LLC

  • $567 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$5.85 - $9.84 $58,500 - $98,400
10,000 Added 6.9%
155,000 $959,000
Q4 2022

Feb 14, 2023
BUY
$6.88 - $9.55 $275,200 - $382,000
40,000 Added 38.1%
145,000 $1.34 Million
Q2 2022

Aug 15, 2022
BUY
$7.65 - $14.24 $803,250 - $1.5 Million
105,000 New
105,000 $1.07 Million

Others Institutions Holding ALEC

# of Institutions
168
Shares Held
57.8M
Call Options Held
146K
Put Options Held
90.8K
View Full List

About Alector, Inc.

ALEC Quotes by TradingView
  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $159M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Newtyn Management, LLC Portfolio

Follow Newtyn Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newtyn Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Newtyn Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email